GlassScriptPhysician profile
Deven B Patel
NPI 1013597863
$15,478.67
in general payments reported to CMS, 2019-2025
19 companies · $1,689 in 2025
The $1,689 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,900 · 2022: $4,158 · 2023: $2,007 · 2024: $5,725 · 2025: $1,689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,594 · Travel and Lodging: $2,827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,593.76 |
| Travel and Lodging | $2,826.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,247.70 | 2021-2025 | Ortholoc 3di, Easyfuse, Citrefix |
| Legacy Ortho LLC | $3,739.35 | 2021-2024 | |
| Orthofix Medical, INC. | $2,413.10 | 2022-2024 | Truelok |
| Integra Lifesciences Corporation | $564.50 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bone Support INC. | $395.76 | 2022-2025 | Ceramentbone Void Filler, Cerament G |
| Smith+Nephew, INC. | $350.75 | 2022-2025 | Stravix, Collagenase Santyl, Grafix Pl |
| Paragon 28, INC. | $294.12 | 2024 | Precision Mis Bunion, Baby Gorilla |
| Imperative Care, INC | $290.24 | 2023 | Prodigy Catheter |
| Bioventus LLC | $270.65 | 2021-2022 | |
| Amgen INC. | $248.82 | 2024 | Krystexxa |
| Treace Medical Concepts, INC. | $148.16 | 2023 | |
| Truvic Medical, INC. | $133.49 | 2022 | |
| Horizon Therapeutics Plc | $124.99 | 2023 | Krystexxa |
| Kerecis Limited | $96.92 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sanara Medtech INC. | $50.51 | 2023 | Celleraterx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $48.33 | 2025 | Magnetos |
| Biotissue Holdings INC. | $31.96 | 2025 | |
| Pfizer INC. | $16.56 | 2021 | |
| Depuy Synthes Sales INC. | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deven Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.